Haemonetics (HAE) announced that it has entered into a definitive agreement to sell its whole blood assets to GVS, a manufacturer of filter ...

Haemonetics to sell whole blood assets to GVS for $67.1 million: Boston Wednesday, December 4, 2024, 10:00 Hrs [IST] Haemonetics Corporation, a global medical technology company f ...

Haemonetics (NYSE:HAE) announced today that it agreed to sell its whole blood assets to GVS S.p.A for $67.1 million.

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a ...

Alyx is designed to help optimize your bottom line with reduced labor and error related costs and the ability to increase collection of high value components.

Amicus™ high collection efficiency yields multiple products per donor for the lowest-cost platelet production. It is designed to adapt to the requirements of different collection settings. Let ...

CRISPR Therapeutics ($CRSP) has endured a tough year since gaining several important regulatory approvals for its ...

After hours: November 29 at 1:02 PM EST Loading Chart for CYRX ...

In this disturbing outbreak of COVID-19, the only advice we are getting is to stay home and stay safe. While it is absolutely very important to stay indoors but it necessarily doesn't translate to ...